申请人:Istituto di Ricerche di Biologia Molecolare P. Angeletti SpA
公开号:US08178520B2
公开(公告)日:2012-05-15
The present invention relates to macrocyclic compounds of formula (I): wherein W, n, R1, Ra, Rb, R3, R4, M, Z, ring A and ring B are defined herein, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising them, and their use for the treatment or prevention of infection by hepatitis C virus.
本发明涉及公式(I)的大环化合物:其中W,n,R1,Ra,Rb,R3,R4,M,Z,环A和环B在此定义,并且它们的药学上可接受的盐,包括它们的制药组合物以及它们用于治疗或预防丙型肝炎病毒感染的用途。